Clinical trial
Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine
NCT05800236 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 22, 2023
- Completion date
- March 31, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric adenocarcinoma